Midostaurin for Acute Myeloid Leukaemia (AML)

What's in this booklet? 

Midostaurin is a multi-targeted protein kinase inhibitor. Midostaurin has been approved for the treatment of adult patients with AML.

This hardcopy version of our booklet can be ordered free of charge to UK addresses. 

Digital downloads

To access an instant download of our Midostaurin for Acute myeloid leukaemia (AML) information booklet, please click here (opens as a PDF file). 

Each booklet takes us approximately six months to write and is supplied free of charge to patients, families and hospitals across the UK. It costs us approximately £3 to provide one booklet. Please consider adding a donation to your order if you can.